共 134 条
[1]
Siegel RL(2023)Cancer statistics, 2023 CA Cancer J Clin 73 17-48
[2]
Miller KD(2016)Non-small cell Lung cancer: current treatment and future advances Transl Lung Cancer Res 5 288-300
[3]
Wagle NS(2019)Abandoning the notion of Non-small Cell Lung Cancer Trends Mol Med 25 585-94
[4]
Zappa C(2021)Advances in systemic therapy for non-small cell Lung cancer BMJ 375 n2363-93
[5]
Mousa SA(2023)Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell Lung cancer: current status and perspectives Biomark Res 11 7-50
[6]
Relli V(2020)The role of ubiquitination in tumorigenesis and targeted drug discovery Signal Transduct Target Ther 5 11-50
[7]
Trerotola M(2018)Ubiquitination: friend and foe in cancer Int J Biochem Cell Biol 101 80-70
[8]
Guerra E(2022)Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation Chem Soc Rev 51 5330-66
[9]
Miller M(2022)Proteolysis-targeting chimeras (PROTACs) in cancer therapy Mol Cancer 21 99-97
[10]
Hanna N(2022)Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders Chem Soc Rev 51 6234-70